Sucampo Pharma Europe is a research-oriented pharmaceutical company focusing on the development and commercialization of novel therapies based on prostones to treat diseases and disorders for which there are unmet and underserved medical needs.

Established in London, UK in June 2002, Sucampo Pharma Europe is a member of the Sucampo Group, an international affiliation of companies whose aim is to bring new classes of pharmaceutical products to global market based upon proprietary technologies. As an operating company of Sucampo Group, Sucampo Pharma Europe is responsible for the development and marketing of pharmaceutical products in Europe, Middle East and Africa.